Table 2. The spectrum of biopsy-proven renal disease in patients with NDRD.
The table shows the incidence of specific pathological diagnosis in patients with NDRD and NDRD + DN.
| NDRD | NDRD + DN | |
|---|---|---|
| Membraneous nephropathy | 323 (39.3%) | 34 (33.7%) |
| IgA nephropathy | 147 (17.9%) | 32 (31.7%)a |
| Minimal change disease | 110 (13.4%) | 0a |
| Mesangial proliferative glomerulonephritis | 67 (8.2%) | 0a |
| Focal segmental glomerulosclerosis | 46 (5.6%) | 1 (1.0%)a |
| Acute tubular necrosis | 15 (1.8%) | 1 (1.0%) |
| Tubulointerstitial nephropathy | 15 (1.8%) | 12 (11.9%)a |
| Hypertensive renal disease | 14 (1.7%) | 18 (17.8%)a |
| HBV-associated nephritis | 13 (1.6%) | 0 |
| Lupus nephritis | 12 (1.5%) | 0 |
| Henoch-Schonlein Purpura nephritis | 12 (1.5%) | 1 (1.0%) |
| ANCA-associated vasculitis | 7 (0.9%) | 0 |
| Proliferative sclerotic glomerulonephritis | 5 (0.6%) | 0 |
| Membraneous proliferative glomerulonephritis | 4 (0.5%) | 0 |
| Obesity associated nephropathy | 4 (0.5%) | 0 |
| Thin basement membrane nephropathy | 4 (0.5%) | 0 |
| Endocapillary proliferative glomerulonephritis | 2 (0.2%) | 0 |
| Amyloidosis-AL subtype | 2 (0.2%) | 0 |
| Amyloidosis | 2 (0.2%) | 0 |
| Mesangial nodular nephropathy | 2 (0.2%) | 0 |
| Focal glomerulonephritis | 1 (0.1%) | 0 |
| Crescentic glomerulonephritis | 1 (0.1%) | 0 |
| Immunotactoid glomerulopathy | 1 (0.1%) | 0 |
| Microscopic polyangiitis | 1 (0.1%) | 0 |
| Eosinophilic granulomatosis with polyangiitis | 1 (0.1%) | 0 |
| Light chain deposition disease | 1 (0.1%) | 0 |
| Fibrillary glomerulopathy | 0 | 2 (2.0%)a |
| Others | 10 (1.2%) | 0 |
| Total | 822 | 101 |
Notes.
Values are expressed as frequencies and percentages (n(%)).
- NDRD
- non-diabetic renal disease
- DN
- diabetic nephropathy
Differences were analyzed by χ2 test or Fisher’s Exact tests, if appropriate.
a
P < 0.05 for comparison of NDRD + DN versus NDRD.